Article

Alzheimer's Disease Neuroimaging Initiative (2009): Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls

Laboratory of Neuro Imaging, Department of Neurology, UCLA School of Medicine, Los Angeles, California 90095-1769, USA.
Human Brain Mapping (Impact Factor: 6.92). 09/2009; 30(9):2766-88. DOI: 10.1002/hbm.20708
Source: PubMed

ABSTRACT We used a new method we developed for automated hippocampal segmentation, called the auto context model, to analyze brain MRI scans of 400 subjects from the Alzheimer's disease neuroimaging initiative. After training the classifier on 21 hand-labeled expert segmentations, we created binary maps of the hippocampus for three age- and sex-matched groups: 100 subjects with Alzheimer's disease (AD), 200 with mild cognitive impairment (MCI) and 100 elderly controls (mean age: 75.84; SD: 6.64). Hippocampal traces were converted to parametric surface meshes and a radial atrophy mapping technique was used to compute average surface models and local statistics of atrophy. Surface-based statistical maps visualized links between regional atrophy and diagnosis (MCI versus controls: P = 0.008; MCI versus AD: P = 0.001), mini-mental state exam (MMSE) scores, and global and sum-of-boxes clinical dementia rating scores (CDR; all P < 0.0001, corrected). Right but not left hippocampal atrophy was associated with geriatric depression scores (P = 0.004, corrected); hippocampal atrophy was not associated with subsequent decline in MMSE and CDR scores, educational level, ApoE genotype, systolic or diastolic blood pressure measures, or homocysteine. We gradually reduced sample sizes and used false discovery rate curves to examine the method's power to detect associations with diagnosis and cognition in smaller samples. Forty subjects were sufficient to discriminate AD from normal and correlate atrophy with CDR scores; 104, 200, and 304 subjects, respectively, were required to correlate MMSE with atrophy, to distinguish MCI from normal, and MCI from AD.

Download full-text

Full-text

Available from: Paul Thompson, Aug 29, 2015
0 Followers
 · 
143 Views
  • Source
    • "The hippocampus plays a central role in early memory loss in AD patients [5]. The earliest neuropathological changes in AD are consistently observed in the medial temporal lobe (entorhinal cortex and hippocampus) [6], and hippocampal volume loss is the best established diagnostic marker for AD and highly predictive of disease progression [7]. Early deficits in hippocampal memory performance and synaptic plasticity have been established in various animal models of AD, before neuropathological changes are observed and in the absence of neurodegeneration [8,9]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Alzheimer’s disease is caused by increased production or reduced clearance of amyloid-β, which results in the formation amyloid-β plaques and triggers a cascade of downstream events leading to progressive neurodegeneration. The earliest clinical symptoms of Alzheimer’s disease, i.e., memory loss, are however poorly understood from a molecular and cellular perspective. Here we used APPswe/PS1dE9 (APP/PS1) transgenic mice to study the early pre-pathological effects of increased amyloid-β levels on hippocampal synaptic plasticity and memory. Using an unbiased proteomics approach we show that the early increase in amyloid-β levels in APP/PS1 mice at three months of age coincides with a robust and significant upregulation of several protein components of the extracellular matrix in hippocampal synaptosome preparations. This increase in extracellular matrix levels occurred well before the onset of plaque formation and was paralleled by impairments in hippocampal long-term potentiation and contextual memory. Direct injection into the hippocampus of the extracellular matrix inactivating enzyme chondroitinase ABC restored both long-term potentiation and contextual memory performance. These findings indicate an important role for the extracellular matrix in causing early memory loss in Alzheimer’s disease. Electronic supplementary material The online version of this article (doi:10.1186/s40478-014-0076-z) contains supplementary material, which is available to authorized users.
    06/2014; 2(1):76. DOI:10.1186/PREACCEPT-1259006781131998
  • Source
    • "The most pronounced atrophy in AD has been found in the anterior hippocampus (as well as posterior parahippocampal gyrus and the precuneus) compared to age-matched controls (Raji et al., 2009). Moreover, hippocampal head (anterior) atrophy has been reported as a predictive marker of conversion to AD (Csernansky et al., 2005; Apostolova et al., 2006; Morra et al., 2009a; Costafreda et al., 2011). Costafreda et al. identified more pronounced changes in the right lateral and medial aspects of hippocampal head in individuals that later converted to AD and his results correspond with previous reports of anterior CA1 (Csernansky et al., 2005; Apostolova et al., 2006; Costafreda et al., 2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The hippocampus is one of the earliest affected brain regions in Alzheimer's disease (AD) and its dysfunction is believed to underlie the core feature of the disease-memory impairment. Given that hippocampal volume is one of the best AD biomarkers, our review focuses on distinct subfields within the hippocampus, pinpointing regions that might enhance the predictive value of current diagnostic methods. Our review presents how changes in hippocampal volume, shape, symmetry and activation are reflected by cognitive impairment and how they are linked with neurogenesis alterations. Moreover, we revisit the functional differentiation along the anteroposterior longitudinal axis of the hippocampus and discuss its relevance for AD diagnosis. Finally, we indicate that apart from hippocampal subfield volumetry, the characteristic pattern of hippocampal hyperactivation associated with seizures and neurogenesis changes is another promising candidate for an early AD biomarker that could become also a target for early interventions.
    Frontiers in Cellular Neuroscience 03/2014; 8:95. DOI:10.3389/fncel.2014.00095 · 4.18 Impact Factor
  • Source
    • "For example, obvious pathological changes within the hippocampal formation occur in Alzheimer's disease and related dementias, associated with the memory impairments observed in these disorders (Hodges, 2012). Some level of hippocampal pathology is thought to contribute to major depression that occurs late in life, which also may relate to mild cognitive impairment (MCI; Morra et al., 2009). Additionally, a very complex interplay exists between TBV, aging and hippocampal volume and the transitions from healthy aging to MCI, and from MCI to frank dementia (Apostolova et al., 2012). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Depending on severity, traumatic brain injury (TBI) induces immediate neuropathological effects that in the mildest form may be transient but as severity increases results in neural damage and degeneration. The first phase of neural degeneration is explainable by the primary acute and secondary neuropathological effects initiated by the injury; however, neuroimaging studies demonstrate a prolonged period of pathological changes that progressively occur even during the chronic phase. This review examines how neuroimaging may be used in TBI to understand (1) the dynamic changes that occur in brain development relevant to understanding the effects of TBI and how these relate to developmental stage when the brain is injured, (2) how TBI interferes with age-typical brain development and the effects of aging thereafter, and (3) how TBI results in greater frontotemporolimbic damage, results in cerebral atrophy, and is more disruptive to white matter neural connectivity. Neuroimaging quantification in TBI demonstrates degenerative effects from brain injury over time. An adverse synergistic influence of TBI with aging may predispose the brain injured individual for the development of neuropsychiatric and neurodegenerative disorders long after surviving the brain injury.
    Frontiers in Human Neuroscience 08/2013; 7:395. DOI:10.3389/fnhum.2013.00395 · 2.90 Impact Factor
Show more